iso-211At-SAGMB-VHH-2001

N/A

Report date: 2025/11/05 17:48:31

Base Information

Drug Nameiso-211At-SAGMB-VHH-2001

Drug Alias Nameiso-[211At]SAGMB-VHH_2001iso-211At-SAGMB-VHH_2001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentRadiation-emitting products > Nuclides > Astatine > 211AtRadiation-emitting products > Radioactive therapeutic agent +[5]

Mechanisms of ActionAnti-HER2

TargetsReceptor protein-tyrosine kinase erbB-2

Therapy Area/IndicationsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesDuke University

China Registration ClassN/A

Develop Information

Active CompaniesDuke University

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A